Home/Neurotech Pharmaceuticals/Rob Kissling, MD

RK

Rob Kissling, MD

Leadership Team (inferred)

Neurotech Pharmaceuticals

Therapeutic Areas

Ophthalmology Retinal Diseases

Neurotech Pharmaceuticals Pipeline

Drug	Indication	Phase
ENCELTO™ (revakinagene taroretcel-lwey) / NT-501	Idiopathic Macular Telangiectasia Type 2 (MacTel)	Approved

Leadership Team at Neurotech Pharmaceuticals

Chief Executive Officer

Chief Commercial Officer

Lead Director, Board of Directors

View full Neurotech Pharmaceuticals profile